Vanilloid-sensitive neurons: A fundamental subdivision of the peripheral nervous system

Journal of the Peripheral Nervous System

Volumn 1, Issue 1, 1996, Pages 6-18

  Szallasi, Arpad ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; DRUG RECEPTOR;

ANIMAL; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; NERVE CELL; NERVE CELL PLASTICITY; PERIPHERAL NERVE; PHYSIOLOGY; RAT; REVIEW; SECOND MESSENGER;

ALKALOIDS; ANIMALS; HUMANS; NEURONAL PLASTICITY; NEURONS; PERIPHERAL NERVES; RATS; RECEPTORS, DRUG; SECOND MESSENGER SYSTEMS;

EID: 0030307629     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Lee TS: Physiological gustatory sweating in warm climate. J. Physiol. (Lond) 1954; 124:528-542.
2. Jancsó-Gábor A, Szolcsányi J, Jancsó N: Stimulation and desensitization of the hypothalamic heat sensitive structure by capsaicin in rats. J. Physiol. (Lond) 1970; 206: 495-507.
3. Rozin P, Schiller D: The nature and acquisition of a preference for chili pepper by humans. Motiv. Emotion 1980; 1:77-101.
4. López-Carillo L, Hernández Avila M, Dubrow R: Chili pepper consumption and gastric cancer in Mexico: a case-control study. Am. J. Epidemiol. 1994; 139:263-271.
5. Surh Y-J, Lee SS: Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci. 1995; 56:1845-1855.
6. Jancsó N: Role of nerve terminals in the mechanism of inflammatory reactions. Bull. Millard Fillmore Hosp. Buffalo NY. 1960; 7:53-77.
7. Jancsó N: Desensitization with capsaicin and related acylamides as a tool for studying the function of pain receptors. In: Pharmacology of Pain (Lin K, Armstrong D, Pardo EG, eds). Oxford: Pergamon Press, 1968, pp 33-55.
8. Buck SH, Burks TF: The neuropharmacology of capsaicin: a review of some recent observations. Pharmacol. Rev. 1986; 38:179-226.
9. Holzer P: Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 1991; 43:144-201.
10. Maggi CA, Meli A: The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen. Pharmacol. 19:1-43.
11. Winter J, Bevan S, Campbell EA: Capsaicin and pain mechanisms. Br. J. Anaesth. 1995; 75:157-168.
12. Carter RB: Topical capsaicin in the treatment of cutaneous disorders. Drug Dev. Res. 1991; 22:109-123.
13. Rumsfield JA, West DP: Topical capsaicin in dermatologic and peripheral pain disorders. DICP Ann. Pharmacother. 1991; 25:381-387.
14. Coleridge JCG, Coleridge HM: Afferent vagal C-fibre innervation of the lung and airways and its functional significance. Rev. Physiol. Biochem. Pharmacol. 1984; 99:1-110.
15. Ritter S, Ritter RC: Capsaicin-sensitivity and the sensory vagus: do these exceptions prove or disprove the B-neuron rule for autonomic afferents? Behavior. Brain Res. 1990; 13:315-316.
16. Wood JN (ed): Capsaicin in the Study of Pain. New York: Academic Press, 1993.
17. Szallasi A, Blumberg PM: Resiniferatoxin and its analogs provide novel insights into the pharmacology of vanilloid (capsaicin) receptors. Life Sci. 1990; 47:1399-1408.
18. Blumberg PM, Szallasi A, Acs G: Resiniferatoxin - an ultrapotent capsaicin analogue. In: Capsaicin in the Study of Pain (Wood JN, ed). New York: Academic Press, 1993, pp 45-62.
19. Szallasi A: The vanilloid (capsaicin) receptor: receptor types and species differences. Gen. Pharmacol. 1994; 25:223-243.
20. Szallasi A, Blumberg PM: Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes. Brain Res. 1990; 524:106-111.
21. Docherty RJ, Robertson B, Bevan S: Capsaicin causes prolonged inhibition of voltage-activated calcium currents in adult dorsal root ganglion neurons in culture. Neuroscience 1991; 40:513-521.
22. Baccaglini PI, Hogan PG: Some rat sensory neurons in culture express characteristics of differentiated pain cell. Proc. Natl. Acad. Sci. USA 1983; 80:594-598.
23. 2+ dependence in rat trigeminal ganglion cells. J. Neurophysiol. 1996; 75:1503-1514.
24. Liu L, Wang Y, Simon SA: Capsaicin activated currents in rat dorsal root ganglion cells. Pain 1996; 64:191-195.
25. Jancsó G, Király E, Jancsó-Gábor A: Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 1977; 270:741-743.
26. Szallasi A, Nilsson S, Farkas-Szallasi T, Blumberg PM, Hökfelt T, Lundberg JM: Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res. 1995; 703:175-183.
27. 3H]resiniferatoxin autoradiography of capsaicin-sensitive neurons in the rat, pig and man. Eur. J. Pharmacol. 1994; 264:217-221.
28. 3H]resiniferatoxin binding by the vanilloid receptor: species-related differences, effects of temperature and sulfhydryl reagents. Naunyn-Schmiedeberg's Arch. Pharmacol. 1993; 347:84-91.
29. 3H]resiniferatoxin binding by the vanilloid (capsaicin) receptor in dorsal root ganglia, spinal cord, dorsal vagal complex, sciatic and vagal nerve and urinary bladder of the rat. Life Sci. 1994; 55:1017-1026.
30. Szallasi A, Conte B, Goso C, Blumberg PM, Manzini S: Vanilloid receptors in the urinary bladder: regional distribution, localization on sensory nerves, and species-related differences. Naunyn-Schmiedeberg's Arch. Pharmacol. 1993; 347:624-629.
31. Szallasi A: Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man. Acta Physiol. Scand. 1995; 155(Suppl. 629):1-68.
32. Sporn MB, Roberts AB: Peptide growth factors are multifunctional. Nature 1988; 332:217-220.
33. Holzer P, Sametz W: Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology 1986; 91:975-981.
34. Holzer P: Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988; 24:739-768.
35. Thomas DA, Dubner R, Ruda MA: Neonatal capsaicin treatment in rats results in scratching behavior with skin damage: potential model of non-painful dysesthesia. Neurosci. Lett. 1994; 171:101-104.
36. Holzer P, Saria A, Skofitsch G, Lembeck F: Increase in tissue concentrations of histamine and 5-hydroxytryptamine following capsaicin treatment of newborn rats. Life Sci. 1981; 29:1099-1105.
37. McMahon SB, Lewin G, Bloom SR: The consequences of long term topical capsaicin application in the rat. Pain 1991; 44:301-310.
38. Hökfelt T: Neuropeptides in perspective: the last ten years. Neuron 1991; 7:867-879.
39. Weihe E: Neuropeptides in primary afferent neurons. In: The Primary Afferent Neuron (Zenker W, Neuhuber WL, eds). New York: Plenum Press, 1990, pp. 127-159.
40. Buck SH (ed): The Tachykinin Receptors. Totowa: Humana Press, 1994.
41. Zhang X: Messenger Pasticity in Primary Sensory Neurons following Peripheral Nerve Injury. Stockholm: Karolinska Institute (PhD Thesis), 1994.
42. Lundberg JM, Saria A: Capsaicin-induced desensitization of the airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature 1983; 302:251-253.
43. Greiff L, Svensson C, Andersson M, Persson CGA: Effects of topical capsaicin in seasonal allergic rhinitis. Thorax 1995; 50:225-229.
44. Szallasi A, Goso C, Manzini S: Resiniferatoxin binding to vanilloid receptors in guinea pig and human airways. Am. J. Resp. Crit. Care Med. 1995; 152:59-63.
45. 3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder, airways) vanilloid (capsaicin) receptors in the rat. J. Pharmacol. Exp. Ther. 1993; 267:728-733.
46. Ingram SL, Martenson ME, Baumann TK: Responses of cultured adult monkey trigeminal ganglion neurons to capsaicin. NeuroReport 1993; 4:460-462.
47. 3H]resiniferatoxin binding of a human vanilloid (capsaicin) receptor in post-mortem spinal cord. Neurosci. Lett. 1994; 165:101-104.
48. 3H]resiniferatoxin binding by the human vanilloid (capsaicin) receptor. Mol. Brain Res. 1994; 23:185-190.
49. 3H]resiniferatoxin binding to pig dorsal horn membranes displays positive cooperativity. Life Sci. 1994; 55:337-346.
50. Rinder J, Szallasi A, Lundberg JM: Capsaicin-, resiniferatoxin-, and lactic acid-evoked vascular effects in the pig nasal mucosa in vivo with reference to characterization of the vanilloid receptor. Pharmacol. Toxicol. 1996; 78:327-335.
51. Hökfelt T, Zhang X, Wiesenfeld-Hallin Z: Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 1994; 17:22-30.
52. Stanfa L, Dickenson A, Xu XJ, Wiesenfeld-Hallin Z: Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol. Sci. 1994; 15:65-66.
53. Szolcsányi J, Szallasi A, Szallasi Z, Joó F, Blumberg PM: Resiniferatoxin, an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons. J. Pharmacol. Exp. Ther. 1990; 255:923-928.
54. Anand P, Gibson SJ, Scaravilli F, Blank MA, McGregor GP, Appenzeller O, Dhital K, Polak JM, Bloom SR: Studies of vasoactive intestinal polypeptide expression in injured peripheral neurons using capsaicin, sympathectomy and inf mutant rats. Neurosci. Lett. 1990; 118:61-66.
55. Leah JD, Herdegen T, Bravo R: Selective expression of Jun proteins following axotomy and axonal transport block in peripheral nerves in the rat: evidence for a role in the regeneration process. Brain Res. 1991; 566:198-201.
56. Jancsó G: Pathobiological reactions of primary sensory neurones to peripheral nerve injury. Exp. Physiol. 1992; 77:405-431.
57. Farkas-Szallasi T, Lundberg JM, Wiesenfeld-Hallin Z, Hökfelt T, Szallasi A: Increased levels of GMAP, VIP and nitric oxide synthase, and their mRNAs, in lumbar dorsal root ganglia of the rat following systemic resiniferatoxin treatment. NeuroReport 1995; 6:2230-2234.
58. Devor M, Raber P: Heritability of symptoms in an experimental model of neuropathic pain. Pain 1990; 42:51-67.
59. Yanagisawa M, Yagi N, Otsuka M, Yanaihara C, Yanaihara N: Inhibitory effects of galanin on the isolated spinal cord of the newborn rat. Neurosci. Lett. 1986; 70:278-282.
60. Meller ST, Gebhart GF: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52:127-136.
61. Wiesenfeld-Hallin Z, Xu XJ, Håkanson R, Feng DM, Folkers K: Plasticity of peptidergic mediation of spinal reflex facilitation after peripheral nerve section. Neurosci. Lett. 1990; 116:293-298.
62. Wall PD, Melzack R (eds): Textbook of Pain. Edinburgh, London, Melbourne, New York: Churchill Livingstone, 1984.
63. Willis WD: The Pain System. Basel: S. Karger, 1985.
64. Hao JX, Yu W, Xu XJ, Wiesenfeld-Hallin Z: Capsaicin-sensitive afferents mediate chronic cold, but not mechanical, allodynia-like behaviour in spinally injured rats. Brain Res.; 722:177-180.
65. Farkas-Szallasi T, Bennett GJ, Blumberg PM, Hökfelt T, Lundberg JM, Szallasi A: Vanilloid receptor loss is independent of the messenger plasticity that follows systemic resiniferatoxin administration. Brain Res. 1996; 719:213-218.
66. Szallasi A, Blumberg PM: Vanilloid receptor loss in rat sensory ganglia associated with long term desensitization to resiniferatoxin. Neurosci. Lett. 1992; 136:51-54.
67. Goso C, Piovacari G, Szallasi A: Resiniferatoxin-induced loss of vanilloid receptors is reversible in the urinary bladder but not in the spinal cord of the rat. Neurosci. Lett. 1993; 162:197-200.
68. Miller MS, Buck SH, Sipes IG, Yamamura HI, Burks TF: Regulation of substance P by nerve growth factor: disruption by capsaicin. Brain Res. 1982; 250:193-196.
69. Otten U, Lorez HP, Businger F: Nerve growth factor antagonizes the neurotoxic action of capsaicin on primary sensory neurones. Nature 1983; 301:515-517.
70. Winter J, Forbes CA, Sternberg J, Lindsay RM: Nerve growth factor (NGF) regulates adult rat dorsal root ganglion neuron responses to capsaicin. Neuron 1988; 1:973-981.
71. Bevan S, Winter J: Nerve growth factor (NGF) differentially regulates the chemosensitivity of adult cultured sensory neurons. J. Neurosci. 1995; 15:4918-4926.
72. Ninkina NN, Buchman VL, Akopian AN, Lawson SN, Yamamoto M, Campbell E, Corcoran L, Wood JN: Nerve growth factor-regulated properties of sensory neurones in Oct-2 null mutant mice. Mol. Brain Res. 1995; 33:233-244.
73. Hu-Tsai M, Woolf C, Winter J: Influence of inflammation or disconnection from peripheral target tissue on the capsaicin sensitivity of rat dorsal root ganglion sensory neurones. Neurosci. Lett. 1996; 203:119-122.
74. 45Ca uptake and for high affinity binding in cultured rat dorsal root ganglion neurons and dorsal root ganglion membranes. Mol. Brain Res. 1996; 35:173-182.
75. Szallasi A, Blumberg PM: Molecular target size of the vanilloid (capsaicin) receptor in pig dorsal root ganglia. Life Sci. 1991; 48:1863-1869.
76. Szallasi A, Acs G, Cravotto G, Blumberg PM, Lundberg JM, Appendino G: A novel agonist, phorbol 12-phenyl-acetate 13-acetate 20-homovanillate, abolishes positive cooperatively of binding by the vanilloid receptor. Eur. J. Pharmacol. 1996; 299:221-228.
77. Appendino G, Cravotto G, Palmisano G, Annunziata R, Szallasi A: Synthesis and evaluation of phorboid-20-homovanillates. Discovery of a class of ligands binding to the vanilloid receptor with different degrees of cooperativity. J. Med. Chem. 1996; in press.
78. Joó F, Szolcsányi J, Jancsó-Gábor A: Mitochondrial alterations in the spinal ganglion cells of the rat accompanying the long-lasting sensory disturbance induced by capsaicin. Life Sci. 1969; 8:621-626.
79. Yeats JC, Boddeke HWGM, Docherty RJ: Capsaicin desensitization in rat dorsal root ganglion neurones is due to activation of calcineurin. Br. J. Pharmacol. 1992; 107(Suppl.):238P.
80. Bleakman D, Brorson JR, Miller RJ: The effect of capsaicin on voltage-gated calcium currents and calcium signals in cultured dorsal root ganglion cells. Br. J. Pharmacol. 1990; 101:423-431.
81. Amann R, Maggi CA: Ruthenium red as a capsaicin antagonist. Life Sci. 1991; 49:849-856.
82. Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, Walpole CSJ, Yeats JC: Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br. J. Pharmacol. 1992; 107:544-552.
83. Szallasi A, Jonassohn M, Ács G, Biró T, Ács P, Blumberg PM, Sterner O: The stimulation of capsaicin-sensitive neurones in a vanilloid receptor-mediated fashion by pungent terpenoids possessing an unsaturated 1,4-dialdehyde moiety. Br. J. Pharmacol. 1996; in press.
84. Bevan S, Geppetti P: Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci. 1994; 17:509-512.
85. 3H]resiniferatoxin binding to vanilloid (capsaicin) receptors in rat spinal cord. Eur. J. Pharmacol. 1995; 289:181-187.
86. Liu L, Simon SA: A rapid capsaicin-activated current in rat trigeminal ganglion neurons. Proc. Natl. Acad. Sci. USA 1994; 91:738-741.
87. 45Ca uptake by adult rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. 1995; 274:1090-1098.
88. Szallasi A, Blumberg PM, Hökfelt T, Lundberg JM: Binding of neuroleptic drugs (trifluoperazine and rimcazole) to vanilloid receptors in porcine dorsal horn. Eur. J. Pharmacol. 1996; 298:321-327.
89. Winter J, Dray A, Wood JN, Yeats JC, Bevan S: Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitant. Brain Res. 1990; 520:131-140.
90. Stjärne P, Lundblad L, Änggård A, Lundberg JM: Local capsaicin treatment of the nasal mucosa reduces symptoms in patients with nonallergic nasal hyperreactivity. Am. J. Rhinology 1991; 5:145-151.
91. Philip G, Togias AG: Nonallergic rhinitis. Pathophysiology and models for study. Eur. Arch. Otorhinolaryngol. 1995; 252(Suppl. 1):S27-S32.
92. Szallasi A, Blumberg PM: Mechanisms and therapeutic potential of vanilloids (capsaicin-like molecules). Adv. Pharmacol. 1993; 24:123-155.